CSTL's logo.
Ticker Symbol: CSTL

Castle Biosciences Inc

$54.27 - 17-09-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001447362

Company Profile

Castle Biosciences is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq), cutaneous squamous cell carcinoma (DecisionDx®-SCC), suspicious pigmented lesions (DecisionDx® DiffDx™-Melanoma) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq).Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Health Services
  • Medical/Nursing Services

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $15.65
Change: -$0.78 ( -4.75%)
Days Range: $15.57 - $16.27
Beta: 1.73
52wk. High: $29.59
52wk. Low: $9.26
Ytd. Change -34.95%
50 Day Moving Average: $16.14
200 Day Moving Average: $18.35
Shares Outstanding: 26809728

Valuation

Market Cap: 42.0B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A